Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment (Q58051917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

D Maugendre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Gatel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Massart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

I Guilhem

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Y Lorcy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Lescouarch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Y Herry

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Allannic

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

127-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

Evidence for an effect of antithyroid drugs on the natural history of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00629.X

10.1046/J.1365-2265.1999.00629.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341866%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference